Home › Stocks › PLYX

PLYX — POLARYX THERAPEUTICS INC

Reported value held$7.20M
Funds holding (latest)22
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)13
Institutional value$4.30M · 2.08M sh
New / Add / Cut / Exit2 / 2 / 4 / 3 · Updated 2026-11-16
Top-5 / Top-10 concentration95.5% / 99.7%
Institutional holdings change Reducing -5.0% (-106.10K sh)
Institutional value change Down -26.0%

Fundamentals (SEC EDGAR XBRL)

Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.

Revenue TTM Revenue YoY Net income TTM Net income YoY ROE (TTM) Gross margin Net margin P/E (TTM) P/E pct P/B P/B pct
— — — — — — — — — — —

Wall Street Analyst Consensus

Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19

Consensus ratingBuy
Analysts covering—
12-month price target$7.00 (+334.8%)
Last price at fetch$1.61
Forward P/E (FY1)—
Forward P/E (FY2)—
Revision score (quarter)+0.00
Revision score (year)+0.00
Fiscal quarter end Consensus EPS forecast Forward P/E High EPS Low EPS # estimates Revisions (4wk up/down)
Dec 2026 -0.06 — -0.05 -0.08 2 +1−1
Mar 2027 -0.07 — -0.06 -0.08 2 +1
Jun 2027 -0.06 — -0.06 -0.07 2 +2
Sep 2027 -0.06 — -0.06 -0.07 2 +2
Dec 2027 -0.06 — -0.06 -0.07 2 +1
Fiscal year end Consensus EPS forecast Forward P/E High EPS Low EPS # estimates Revisions (4wk up/down)
Dec 2026 -0.21 — -0.18 -0.23 2 +1−1
Dec 2027 -0.27 — -0.24 -0.30 2 +2
Dec 2028 -0.25 — -0.25 -0.25 1 +1
Dec 2029 -0.23 — -0.23 -0.23 1 +1

Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 13 SEC-registered investment managers reported holding PLYX (POLARYX THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $4.30M across 2.08M shares. That is -5.0% by share count (-106.10K shares) versus the previous quarter, while reported value moved -26.0%. Ownership is concentrated: the five largest holders account for 95.5% of reported value and the top ten for 99.7%.

Compared with the prior quarter, 2 opened new positions, 2 added to existing stakes, 4 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of POLARYX THERAPEUTICS INC (PLYX) include VANGUARD CAPITAL MANAGEMENT LLC, Millennium Management, MILLENNIUM MANAGEMENT LLC, ranked by reported 13F value among the 22 institutional holders on this page.

PLYX is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 13 2.08M $4.30M -4.5%
Q2 2026 13 2.31M $6.13M -0.5%
Q1 2026 15 2.39M $18.10M —

Over the 3 quarters shown, institutional share counts decreased 13% in aggregate (Q1 2026 → Q3 2026).

Top Institutional Holders (Q3 2026) — 13 funds

FundSharesValuePortfolio WeightChange
VANGUARD CAPITAL MANAGEMENT LLC 1.66M $3.43M 0.00% Hold
Geode Capital Management 138.76K $287.41K 0.00% Reduce
VANGUARD FIDUCIARY TRUST CO 80.32K $166.26K 0.00% Reduce
STATE STREET CORP 68.00K $140.77K 0.00% Add
BlackRock Inc 41.01K $84.89K 0.00% Hold
HRT FINANCIAL LP 33.10K $68.00K 0.00% Reduce
Northern Trust Corp 27.99K $57.93K 0.00% Hold
Cerity Partners LLC 10.43K $21.58K 0.00% New
Allworth Financial LP 7.73K $20.55K 0.00% Hold
Vanguard Global Advisers, LLC 6.32K $13.08K 0.00% Hold
UBS Group AG 4.36K $9.02K 0.00% Add
Tower Research Capital LLC (TRC) 1.85K $3.84K 0.00% Reduce
BARCLAYS PLC 9 $19 0.00% New

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 13 funds

FundSharesValuePortfolio WeightChange
VANGUARD CAPITAL MANAGEMENT LLC 1.66M $4.41M 0.00% Hold
GEODE CAPITAL MANAGEMENT, LLC 171.00K $455.08K 0.00% New
Geode Capital Management 171.00K $455.08K 0.00% Hold
VANGUARD FIDUCIARY TRUST CO 105.07K $279.49K 0.00% Hold
HRT FINANCIAL LP 82.09K $218.00K 0.00% New
BlackRock Inc 41.01K $109.09K 0.00% Hold
JANE STREET GROUP, LLC 31.44K $83.63K 0.00% New
Northern Trust Corp 27.99K $74.44K 0.00% Hold
Allworth Financial LP 7.73K $20.55K 0.00% New
Vanguard Global Advisers, LLC 6.32K $16.81K 0.00% Hold
Tower Research Capital LLC (TRC) 3.00K $7.99K 0.00% Add
UBS Group AG 1.28K $3.41K 0.00% Reduce
Fortitude Family Office, LLC 189 $503 0.00% New

Q1 2026 — 15 funds

FundSharesValuePortfolio WeightChange
VANGUARD CAPITAL MANAGEMENT LLC 1.66M $12.54M 0.00% New
Geode Capital Management 170.67K $1.29M 0.00% New
Millennium Management 127.53K $964.09K 0.00% New
MILLENNIUM MANAGEMENT LLC 127.53K $964.09K 0.00% New
VANGUARD FIDUCIARY TRUST CO 104.56K $790.44K 0.00% New
STATE STREET CORP 58.10K $439.27K 0.00% New
BlackRock Inc 41.01K $310.05K 0.00% New
Northern Trust Corp 27.99K $211.58K 0.00% New
Bank of America Corp 25.88K $195.66K 0.00% New
Goldman Sachs Group 13.48K $101.93K 0.00% New
UBS Group AG 13.48K $101.90K 0.00% New
Squarepoint Ops LLC 12.41K $93.79K 0.00% New
Vanguard Global Advisers, LLC 6.32K $47.76K 0.00% New
Morgan Stanley 5.54K $41.91K 0.00% New
Tower Research Capital LLC (TRC) 1.78K $13.46K 0.00% New

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026
VANGUARD CAPITAL MANAGEMENT LLC 1.66M 1.66M 1.66M
Geode Capital Management 138.76K 171.00K 170.67K
VANGUARD FIDUCIARY TRUST CO 80.32K 105.07K 104.56K
STATE STREET CORP 68.00K — 58.10K
BlackRock Inc 41.01K 41.01K 41.01K
HRT FINANCIAL LP 33.10K 82.09K —
Northern Trust Corp 27.99K 27.99K 27.99K
Cerity Partners LLC 10.43K — —
Allworth Financial LP 7.73K 7.73K —
Vanguard Global Advisers, LLC 6.32K 6.32K 6.32K
UBS Group AG 4.36K 1.28K 13.48K
Tower Research Capital LLC (TRC) 1.85K 3.00K 1.78K
BARCLAYS PLC 9 — —
Millennium Management — — 127.53K
MILLENNIUM MANAGEMENT LLC — — 127.53K
GEODE CAPITAL MANAGEMENT, LLC — 171.00K —
Bank of America Corp — — 25.88K
Goldman Sachs Group — — 13.48K
Squarepoint Ops LLC — — 12.41K
JANE STREET GROUP, LLC — 31.44K —

Download holders (CSV)

FAQ

Which funds hold PLYX?

As of 2026-Q3, 13 institutional funds reported holding PLYX (POLARYX THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $4.30M.

How many shares of PLYX do institutions own?

13F filers reported 2.08M shares of PLYX, worth $4.30M in aggregate at the end of 2026-Q3.

Is institutional ownership of PLYX rising or falling?

Share counts moved -5.0% versus the prior quarter — distribution.

Who are the top institutional holders of PLYX?

The largest 13F holders are VANGUARD CAPITAL MANAGEMENT LLC, Millennium Management, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Geode Capital Management; the top 25 are ranked at the top of this page.

Who are the major shareholders of POLARYX THERAPEUTICS INC?

The major shareholders of POLARYX THERAPEUTICS INC (PLYX) by reported 13F value are VANGUARD CAPITAL MANAGEMENT LLC, Millennium Management, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Geode Capital Management, among 22 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own PLYX" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/PLYX/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →